Bacteriophage Therapy Market, By Targeted Bacteria, Disease Indication (Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, & Other), Route of Administration, Distribution Channel & Geography

Description

The global bacteriophage therapy market is estimated to be valued at US$ 1,280.9 million in 2023 and is expected to exhibit a CAGR of 3.7% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,280.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	3.70%	2030 Value Projection:	US$ 1,651.8 Mn

Global Bacteriophage Therapy Market Share (%), By Product Type, 2023

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are one of the most common biological entities that can effectively fight and destroy multi-drug-resistant bacteria. When all antibiotics fail to work against an infection, the phages are able to kill the bacteria causing the infection, thus helping medical professionals save life. Bacteriophages are being considered as a new alternative to antibiotics. In this therapy, the viruses are used to inject their genetic material into bacteria and use their host machinery to multiply themselves. This phage therapy is used to treat or prevent bacterial infections in patients' bodies. Bacteriophage therapy also plays a significant role in the research fields of molecular biology and biotechnology. These factors enhance the potential scope for drug discovery.

Market Dynamics

The increasing organic growth strategies, such as product approval by regulatory authorities to expand key players market portfolio, are expected to drive market growth over the forecast period. For instance, in September 2021, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, announced that the Department of Defense (DoD), an executive branch department of the federal government of the U.S., had awarded the company an additional US$8 million for the continued development of bacteriophage therapies (APT's phage bankTM) for the treatment of infectious diseases. Adaptive Phage Therapeutics, Inc. said that it is thrilled APT's phage bank platform helps to treat drug-resistant infections across multiple indications that create potentially lifesaving therapies for the nation's service members.

Key features of the study:

This report provides an in-depth analysis of the global bacteriophage therapy market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global bacteriophage therapy market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation, OPTIPHARM Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global Bacteriophage Therapy Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriophage therapy market.

Detailed Segmentation:

Global Bacteriophage Therapy Market, By Targeted Bacteria:
- Escherichia coli
- Staphylococcus aureus
- Streptococcus
- Pseudomonas aeruginosa
- Salmonella
- Others
Global Bacteriophage Therapy Market, By Disease Indication:
- Urinary Tract Infections
- Chronic Otitis
- Dental Extraction
- Chronic Ulcerative Colitis
- Bone Infection
- Wound and Skin Infections
- Cystic Fibrosis
- Others
Global Bacteriophage Therapy Market, By Route of Administration:
- Oral
- Topical
- Parenteral
Global Bacteriophage Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Bacteriophage Therapy Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Armata Pharmaceuticals, Inc.
- Eliava Biopreparations Ltd.
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux, Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH.
- PhagePro, Inc.
- Adaptive Phage Therapeutics
- Enbiotix, Inc.
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd.
- Micreos BV
- ContraFect Corporation
- OPTIPHARM Co., Ltd.

Product Code: CMI2752

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Targeted Bacteria
- Market Snippet, By Disease Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Bacteriophage Therapy Market, - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Bacteriophage Therapy Market, By Targeted Bacteria, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Escherichia coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Streptococcus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Pseudomonas aeruginosa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Salmonella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Bacteriophage Therapy Market, By Disease Indication, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Chronic Otitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Dental Extraction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Chronic Ulcerative Colitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Bone Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Wound and Skin Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Bacteriophage Therapy Market, By Route of Administration, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Bacteriophage Therapy Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

9. Global Bacteriophage Therapy Market, By Region, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Targeted Bacteria , 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2018 -2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Mn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profiles
- Armata Pharmaceuticals, Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Eliava Biopreparations Ltd
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux, Inc.
- Intralytix, Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH
- PhagePro, Inc.
- Adaptive Phage Therapeutics
- Enbiotix, Inc
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd
- Micreos BV
- ContraFect Corporation
- OPTIPHARM Co., Ltd.

11. Section

References
Research Methodology
About us and Sales Contact